Back
KalVista Pharmaceuticals Stock Predictions
Sponsored
KALV
Sponsored
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
34
KALV
KalVista Pharmaceuticals
Last Price:
$8.68
Seasonality Move:
-3.06%
7 Day Trial
ALL ACCESS PASS
$
7
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.KalVista Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 2.5% based on the past 9 years of stock performance.
-
KalVista Pharmaceuticals has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is KalVista Pharmaceuticals Stock Undervalued?The current KalVista Pharmaceuticals [KALV] share price is $9.03. The Score for KALV is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
KALV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will KalVista Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 2.5% based on the past 9 years of stock performance.
KalVista Pharmaceuticals Stock Rating
Sell
34
KalVista Pharmaceuticals (KALV)
is a Sell
Is KalVista Pharmaceuticals overpriced?
-
KalVista Pharmaceuticals has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
KalVista Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kalvista.com
52-Week Data
52-Week High:
16.88
52-Week Low:
7.97
Prediction Charts
Market Cap:
446.2M
Price in USD:
9.03
Volume:
152.4K
Beta:
1.26
Technical Analysis
SMA50:
9.86
SMA100:
10.82
SMA200:
11.51
52-Wk Change:
-25.56%
Stock Predictions
-
Is KalVista Pharmaceuticals stock public?Yes, KalVista Pharmaceuticals is a publicly traded company.
-
What is the KalVista Pharmaceuticals stock quote today?The KalVista Pharmaceuticals stock price is 9.03 USD today.
-
How to buy KalVista Pharmaceuticals stock online?You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-13 | 8.61 | 8.69 | 8.91 | 8.48 |
Dec-16 | 8.86 | 8.95 | 9.22 | 8.62 |
Dec-17 | 8.94 | 8.65 | 9.07 | 8.52 |
Dec-18 | 9.30 | 8.49 | 9.30 | 8.25 |
Dec-19 | 8.45 | 8.09 | 8.70 | 8.07 |
Dec-20 | 7.98 | 8.38 | 8.55 | 7.97 |
Dec-23 | 8.46 | 8.83 | 8.86 | 8.15 |
Dec-24 | 8.82 | 8.76 | 8.82 | 8.48 |
Dec-26 | 8.66 | 8.83 | 8.83 | 8.49 |
Dec-27 | 8.77 | 8.53 | 8.80 | 8.46 |
Dec-30 | 8.50 | 8.39 | 8.52 | 8.26 |
Dec-31 | 8.44 | 8.47 | 8.59 | 8.24 |
Jan-2 | 8.60 | 8.86 | 9.04 | 8.48 |
Jan-3 | 8.95 | 9.03 | 9.15 | 8.90 |
KalVista Pharmaceuticals Earnings
KalVista Pharmaceuticals Earnings Report: Per Share KalVista Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
KalVista Pharmaceuticals Forecast Revenue Growth
KalVista Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for KalVista Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.61 per share, and an increase next year of $1.01 per share.
* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.